Biotechking

REGN projection to 750 analyst target

看多
Biotechking 已更新   
NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
Used the pitch fork tool to determine when the current trend would align with the new analyst target of 750. First time using tool. Please provide feedback.
評論:
Going to breakout or down. Earnings aug 5. I’ll beat up.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。